A study of IBI362 for Chinese teens with obesity or overweight
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine, IBI362, to help Chinese adolescents lose weight. It may be an option if you are 12 to 17 years old and have obesity or overweight with a related health condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 17 years old.
- You have obesity or overweight, and if you are overweight, you also have a weight-related health issue like prediabetes, type 2 diabetes, high blood pressure, high cholesterol, fatty liver, or sleep apnea.
- Your weight has stayed within about 11 pounds (5 kg) for at least 12 weeks before joining, despite trying diet and exercise.
- You have not been diagnosed with type 1 diabetes.
- You have gone through puberty (Tanner Stage 2 or higher).
- You have not had any weight-loss surgery (except liposuction or acupuncture more than a year ago).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injectable medicine (IBI362) to see if it helps lower blood pressure in people who are overweight or have obesity. You may be eligible if you have high blood pressure but are not currently taking medication for it, and you do not have diabetes or major heart problems.
This study tests an investigational medication called ecnoglutide to help teenagers lose weight. It is for teens who still have excess weight after trying diet and exercise for at least three months.
This study tests an investigational drug called IBI3040 in healthy adults and in adults who are overweight or obese. It aims to see how the drug affects the body, which may help with weight management. Participants will be monitored closely throughout the study.
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
Hear when a new Adolescents With Obesity or Overweight With Weight-Related Comorbidities trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.